Clinical Trial Update: Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative chemotherapy with low-dose radiotherapy and tislelizumab for locally advanced gastric or gastroesophageal junction adenoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING